• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶然发现对肾细胞癌患者生存的影响:基于701例患者的人群研究结果

Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.

作者信息

Gudbjartsson Tomas, Thoroddsen Asgeir, Petursdottir Vigdis, Hardarson Sverrir, Magnusson Jonas, Einarsson Gudmundur V

机构信息

Department of Urology, Landspitali National University Hospital, Reykjavik, Iceland.

出版信息

Urology. 2005 Dec;66(6):1186-91. doi: 10.1016/j.urology.2005.07.009.

DOI:10.1016/j.urology.2005.07.009
PMID:16360438
Abstract

OBJECTIVES

To conduct a population-based study to evaluate the effect of incidental detection of renal cell carcinoma (RCC) on survival. Incidental detection of RCC has increased significantly in recent years because of widespread use of abdominal imaging. The patients with incidentally diagnosed RCC have better survival; however, because of possible "lead time" bias and stage migration, the real implications of incidental detection on survival have been a matter of debate.

METHODS

All living patients diagnosed with RCC in Iceland between 1971 and 2000 were included (n = 701). The histologic findings were verified, the stage (extent) of the disease was determined, and the incidence, mortality, and survival were evaluated.

RESULTS

The strongest predictors of mortality were stage and nuclear grade. After correcting for these factors in the multivariate analysis, incidental diagnosis, histologic subtype, and gender lost their significance as independent prognostic factors of death. However, the incidentally diagnosed tumors were 2.3 cm smaller on average and at a lower stage and grade than symptomatic tumors, with significantly better patient survival than those with symptomatic tumors on univariate analysis (76% versus 44% 5-year disease-specific survival). An increased incidence of RCC was only seen in men, but incidental detection increased threefold during the study period in both sexes, with significant improvement in survival for the whole group as a result.

CONCLUSIONS

The increased frequency of incidental detection has improved the survival of patients with RCC in Iceland. Incidental detection was not an independent prognostic factor of death, indicating that these tumors are of a similar biologic nature as symptomatic RCCs, only diagnosed earlier.

摘要

目的

开展一项基于人群的研究,以评估肾细胞癌(RCC)偶然发现对生存的影响。由于腹部影像学的广泛应用,近年来RCC的偶然发现显著增加。偶然诊断出的RCC患者生存率更高;然而,由于可能存在“领先时间”偏倚和分期迁移,偶然发现对生存的实际影响一直存在争议。

方法

纳入1971年至2000年间冰岛所有诊断为RCC的在世患者(n = 701)。核实组织学检查结果,确定疾病分期(范围),并评估发病率、死亡率和生存率。

结果

死亡率的最强预测因素是分期和核分级。在多变量分析中校正这些因素后,偶然诊断、组织学亚型和性别作为死亡的独立预后因素失去了意义。然而,偶然诊断出的肿瘤平均比有症状的肿瘤小2.3 cm,分期和分级更低,单变量分析显示其患者生存率明显高于有症状的肿瘤患者(5年疾病特异性生存率分别为76%和44%)。RCC发病率仅在男性中增加,但在研究期间,两性的偶然发现均增加了三倍,结果全组生存率显著提高。

结论

偶然发现频率的增加提高了冰岛RCC患者的生存率。偶然发现不是死亡的独立预后因素,表明这些肿瘤与有症状的RCC具有相似的生物学性质,只是诊断得更早。

相似文献

1
Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.偶然发现对肾细胞癌患者生存的影响:基于701例患者的人群研究结果
Urology. 2005 Dec;66(6):1186-91. doi: 10.1016/j.urology.2005.07.009.
2
Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study.偶然发现的肾细胞癌是一个独立的预后标志物:一项长期的、全人群研究的结果。
J Urol. 2012 Jan;187(1):48-53. doi: 10.1016/j.juro.2011.09.025. Epub 2011 Nov 16.
3
Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.肾细胞癌的组织学亚型和核分级及其对生存的影响:一项对629例患者的全国性回顾性研究。
Eur Urol. 2005 Oct;48(4):593-600. doi: 10.1016/j.eururo.2005.04.016.
4
Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.肿瘤相关症状对肾细胞癌患者预后的影响。
Scand J Urol Nephrol. 2008;42(5):406-11. doi: 10.1080/00365590802022151.
5
Detection, staging and clinical implications of renal cell carcinoma.肾细胞癌的检测、分期及临床意义
Saudi Med J. 2003 Jan;24(1):79-83.
6
[Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005].[1971年至2005年冰岛尸检诊断的肾细胞癌]
Laeknabladid. 2008 Dec;94(12):807-12.
7
[Incidental renal cell carcinoma: analysis of 109 cases].[偶发性肾细胞癌:109例分析]
Zhonghua Wai Ke Za Zhi. 2002 Jun;40(6):445-7.
8
Renal cell carcinoma: incidental detection and pathological staging.肾细胞癌:偶然发现与病理分期
J R Coll Surg Edinb. 2000 Oct;45(5):291-5.
9
Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.年轻与老年患者肾细胞癌的比较:临床病理危险因素及生存情况对比
Scand J Urol Nephrol. 2008;42(2):121-5. doi: 10.1080/00365590701571555.
10
Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases.局限性肾细胞癌的临床症状反映其侵袭潜能:偶然发现病例与有症状病例的对比研究
Urol Oncol. 2006 May-Jun;24(3):201-6. doi: 10.1016/j.urolonc.2005.07.008.

引用本文的文献

1
Revisiting Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Evidence of Survival Benefit with First-Line Immunotherapy and Targeted Therapy Regimens.重新审视转移性肾细胞癌的减瘤性肾切除术:一线免疫治疗和靶向治疗方案生存获益的真实世界证据
J Clin Med. 2025 Aug 6;14(15):5543. doi: 10.3390/jcm14155543.
2
Metastatic Oncocytic Renal Neoplasm Presenting as Gastrointestinal Bleeding.以胃肠道出血为表现的转移性嗜酸性肾肿瘤
Cureus. 2025 May 9;17(5):e83797. doi: 10.7759/cureus.83797. eCollection 2025 May.
3
Validation of novel grading schemes and refinement of the Leibovich risk groups for chromophobe renal cell carcinoma.
新型分级方案的验证及嫌色性肾细胞癌Leibovich风险组的细化
World J Urol. 2024 Dec 23;43(1):45. doi: 10.1007/s00345-024-05394-3.
4
Renal Cell Carcinoma: A Review.肾细胞癌:综述。
JAMA. 2024 Sep 24;332(12):1001-1010. doi: 10.1001/jama.2024.12848.
5
The impact of the COVID-19 pandemic on renal cancer care.COVID-19 大流行对肾癌治疗的影响。
World J Urol. 2024 Apr 13;42(1):231. doi: 10.1007/s00345-024-04925-2.
6
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine.肾细胞癌中的循环游离DNA:精准医学的新时代
Cancers (Basel). 2022 Sep 7;14(18):4359. doi: 10.3390/cancers14184359.
7
Renal cancer stem cell-derived sEVs impair renal function by inducing renal cell ERS and apoptosis in mice.肾癌干细胞衍生的小细胞外囊泡通过诱导小鼠肾细胞内质网应激和凋亡来损害肾功能。
Transl Androl Urol. 2022 May;11(5):578-594. doi: 10.21037/tau-21-1007.
8
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents.转移性肾细胞癌患者起始口服抗癌药物的生存的患者和提供者水平预测因素。
Clin Genitourin Cancer. 2022 Oct;20(5):e396-e405. doi: 10.1016/j.clgc.2022.04.010. Epub 2022 Apr 25.
9
FK506 binding protein 10: a key actor of collagen crosslinking in clear cell renal cell carcinoma.FK506 结合蛋白 10:透明细胞肾细胞癌中胶原交联的关键因素。
Aging (Albany NY). 2021 Aug 13;13(15):19475-19485. doi: 10.18632/aging.203359.
10
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not.晚期肾细胞癌的治疗:免疫疗法已显示出总生存获益,而靶向疗法则未显示出此获益。
Eur Urol Open Sci. 2020 Nov 28;22:61-73. doi: 10.1016/j.euros.2020.11.003. eCollection 2020 Dec.